Ischemia/reperfusion unveils impaired capacity of older adults to restrain oxidative insult

Free Radical Biology and Medicine

Volumn 47, Issue 7, 2009, Pages 1014-1018

  Davies, Sean S ^a   Traustadóttir, Tinna ^b   Stock, Anthoney A ^b   Ye, Fei ^a   Shyr, Yu ^a   Harman, S Mitchell ^b   Roberts II, L Jackson ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b Kronos Longevity Research Institute   (United States)

Author keywords

Aging; Free radicals; Hormone replacement therapy; Ischemia reperfusion; Isoprostanes; Lipid peroxidation; Oxidative injury

Indexed keywords

ISOPROSTANE; SEX HORMONE;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; LIMB ISCHEMIA; LIPID PEROXIDATION; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PATIENT IDENTIFICATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPERFUSION; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; AGING; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REFERENCE VALUES; REPERFUSION INJURY;

EID: 69249229459     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.07.005     Document Type: Article

References (50)

1. Martin G.S., Mannino D.M., and Moss M. The effect of age on the development and outcome of adult sepsis. Crit. Care Med. 34 (2006) 15-21
2. Mosenthal A.C., Lavery R.F., Addis M., Kaul S., Ross S., Marburger R., Deitch E.A., and Livingston D.H. Isolated traumatic brain injury: age is an independent predictor of mortality and early outcome. J. Trauma 52 (2002) 907-911
3. Pereira C.T., Barrow R.E., Sterns A.M., Hawkins H.K., Kimbrough C.W., Jeschke M.G., Lee J.O., Sanford A.P., and Herndon D.N. Age-dependent differences in survival after severe burns: a unicentric review of 1,674 patients and 179 autopsies over 15 years. J. Am. Coll. Surg. 202 (2006) 536-548
4. Cohen H.A., Williams D.O., Holmes Jr. D.R., Selzer F., Kip K.E., Johnston J.M., Holubkov R., Kelsey S.F., and Detre K.M. Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry. Am. Heart J. 146 (2003) 513-519
5. Gutierrez C., Al-Faifi S., Chaparro C., Waddell T., Hadjiliadis D., Singer L., Keshavjee S., and Hutcheon M. The effect of recipient's age on lung transplant outcome. Am. J. Transplant. 7 (2007) 1271-1277
6. Crimi E., Sica V., Williams-Ignarro S., Zhang H., Slutsky A.S., Ignarro L.J., and Napoli C. The role of oxidative stress in adult critical care. Free Radic. Biol. Med. 40 (2006) 398-406
7. Werner C., and Engelhard K. Pathophysiology of traumatic brain injury. Br. J. Anaesth. 99 (2007) 4-9
8. Molavi B., and Mehta J.L. Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr. Opin. Cardiol. 19 (2004) 488-493
9. Ulus A.T., Aksoyek A., Ozkan M., Katircioglu S.F., and Basu S. Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans. Free Radic. Biol. Med. 34 (2003) 911-917
10. Basu S., Meisert I., Eggensperger E., Krieger E., and Krenn C.G. Time course and attenuation of ischaemia-reperfusion induced oxidative injury by propofol in human renal transplantation. Redox Rep. 12 (2007) 195-202
11. Parihar A., Parihar M.S., Milner S., and Bhat S. Oxidative stress and anti-oxidative mobilization in burn injury. Burns 34 (2008) 6-17
12. Powers J.S., Roberts II L.J., Tarvin E., Hongu N., Choi L., and Buchowski M. Oxidative stress and multi-organ failure in hospitalized elderly people. J. Am. Geriatr. Soc. 56 (2008) 1150-1152
13. 4 poisoning. Free Radic. Biol. Med. 38 (2005) 698-710
14. Keaney Jr. J.F., Larson M.G., Vasan R.S., Wilson P.W., Lipinska I., Corey D., Massaro J.M., Sutherland P., Vita J.A., and Benjamin E.J. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 434-439
15. Frisard M.I., Broussard A., Davies S.S., Roberts II L.J., Rood J., de Jonge L., Fang X., Jazwinski S.M., Deutsch W.A., and Ravussin E. Aging, resting metabolic rate, and oxidative damage: results from the Louisiana Healthy Aging Study. J. Gerontol. A Biol. Sci. Med. Sci. 62 (2007) 752-759
16. Sacheck J.M., Milbury P.E., Cannon J.G., Roubenoff R., and Blumberg J.B. Effect of vitamin E and eccentric exercise on selected biomarkers of oxidative stress in young and elderly men. Free Radic. Biol. Med. 34 (2003) 1575-1588
17. Darr D., and Fridovich I. Adaptation to oxidative stress in young, but not in mature or old, Caenorhabditis elegans. Free Radic. Biol. Med. 18 (1995) 195-201
18. Andriollo-Sanchez M., Hininger-Favier I., Meunier N., Venneria E., O'Connor J.M., Maiani G., Coudray C., and Roussel A.M. Age-related oxidative stress and antioxidant parameters in middle-aged and older European subjects: the ZENITH study. Eur. J. Clin. Nutr. 59 Suppl. 2 (2005) S58-62
19. Frei B., Stocker R., and Ames B.N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc. Natl. Acad. Sci. USA 85 (1988) 9748-9752
20. Frei B., England L., and Ames B.N. Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. USA 86 (1989) 6377-6381
21. Long N.C., Suh J., Morrow J.D., Schiestl R.H., Murthy G.G., Brain J.D., and Frei B. Ozone causes lipid peroxidation but little antioxidant depletion in exercising and nonexercising hamsters. J. Appl. Physiol. 91 (2001) 1694-1700
22. Li C., and Jackson R.M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. Cell Physiol. 282 (2002) C227-241
23. Black S.C. In vivo models of myocardial ischemia and reperfusion injury: application to drug discovery and evaluation. J. Pharmacol. Toxicol. Methods 43 (2000) 153-167
24. Kharbanda R.K., Peters M., Walton B., Kattenhorn M., Mullen M., Klein N., Vallance P., Deanfield J., and MacAllister R. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation 103 (2001) 1624-1630
25. Kharbanda R.K., Mortensen U.M., White P.A., Kristiansen S.B., Schmidt M.R., Hoschtitzky J.A., Vogel M., Sorensen K., Redington A.N., and MacAllister R. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 106 (2002) 2881-2883
26. Mancini A., Leone E., Festa R., Grande G., Silvestrini A., De Marinis L., Pontecorvi A., Maira G., Gianpaolo L., and Meucci E. Effects of testosterone on antioxidant systems in male secondary hypogonadism. J. Androl. 29 (2008) 622-629
27. Razmara A., Duckles S.P., Krause D.N., and Procaccio V. Estrogen suppresses brain mitochondrial oxidative stress in female and male rats. Brain Res. 1176 (2007) 71-81
28. Strehlow K., Rotter S., Wassmann S., Adam O., Grohe C., Laufs K., Bohm M., and Nickenig G. Modulation of antioxidant enzyme expression and function by estrogen. Circ. Res. 93 (2003) 170-177
29. Persky A.M., Green P.S., Stubley L., Howell C.O., Zaulyanov L., Brazeau G.A., and Simpkins J.W. Protective effect of estrogens against oxidative damage to heart and skeletal muscle in vivo and in vitro. Proc. Soc. Exp. Biol. Med. 223 (2000) 59-66
30. Hermenegildo C.M.D.P., Oviedo P.J.P., Laguna A.B., Garcia-Perez M.A.P., Tarin J.J.P., and Cano A.M.D.P. Transdermal estradiol reduces F2[alpha]-isoprostane levels in postmenopausal women. Menopause 15 (2008) 714-717
31. Simpkins J.W., Yang S.H., Sarkar S.N., and Pearce V. Estrogen actions on mitochondria-physiological and pathological implications. Mol. Cell. Endocrinol. 290 (2008) 51-59
32. Moosmann B., and Behl C. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc. Natl. Acad. Sci. USA 96 (1999) 8867-8872
33. Ke R.W., Todd Pace D., and Ahokas R.A. Effect of short-term hormone therapy on oxidative stress and endothelial function in African American and Caucasian postmenopausal women. Fertil. Steril. 79 (2003) 1118-1122
34. Morrow J.D., and Roberts L.J. 2nd. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol. 300 (1999) 3-12
35. Pruessner J.C., Kirschbaum C., Meinlschmid G., and Hellhammer D.H. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28 (2003) 916-931
36. May J.M., Qu Z.C., and Mendiratta S. Protection and recycling of alpha-tocopherol in human erythrocytes by intracellular ascorbic acid. Arch. Biochem. Biophys. 349 (1998) 281-289
37. Przybysz A.J., Choe K.P., Roberts II L.J., and Strange K. Increased age reduces DAF-16 and SKN-1 signaling and the hormetic response of Caenorhabditis elegans to the xenobiotic juglone. Mech. Ageing Dev. 130 (2009) 257-369
38. Murphy C.T., McCarroll S.A., Bargmann C.I., Fraser A., Kamath R.S., Ahringer J., Li H., and Kenyon C. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424 (2003) 277-283
39. Lee S.S., Kennedy S., Tolonen A.C., and Ruvkun G. DAF-16 target genes that control C. elegans life-span and metabolism. Science 300 (2003) 644-647
40. McElwee J., Bubb K., and Thomas J.H. Transcriptional outputs of the Caenorhabditis elegans forkhead protein DAF-16. Aging Cell 2 (2003) 111-121
41. Ochoa J.J., Vilchez M.J., Mataix J., Ibanez-Quiles S., Palacios M.A., and Munoz-Hoyos A. Oxidative stress in patients undergoing cardiac surgery: comparative study of revascularization and valve replacement procedures. J. Surg. Res. 111 (2003) 248-254
42. Siow R.C.M., Li F.Y.L., Rowlands D.J., de Winter P., and Mann G.E. Cardiovascular targets for estrogens and phytoestrogens: transcriptional regulation of nitric oxide synthase and antioxidant defense genes. Free Radic. Biol. Med. 42 (2007) 909-925
43. Writing Group for the Women's Health Initiative. I. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
44. Mendelsohn M.E., and Karas R.H. Molecular and cellular basis of cardiovascular gender differences. Science 308 (2005) 1583-1587
45. Rossouw J.E., Prentice R.L., Manson J.E., Wu L., Barad D., Barnabei V.M., Ko M., LaCroix A.Z., Margolis K.L., and Stefanick M.L. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297 (2007) 1465-1477
46. Gomez C.R., Plackett T.P., and Kovacs E.J. Aging and estrogen: modulation of inflammatory responses after injury. Exp. Gerontol. 42 (2007) 451-456
47. Goudeau J.J., Clermont G., Guillery O., Lemaire-Ewing S., Musat A., Vernet M., Vergely C., Guiguet M., Rochette L., and Girard C. In high-risk patients, combination of antiinflammatory procedures during cardiopulmonary bypass can reduce incidences of inflammation and oxidative stress. J. Cardiovasc. Pharmacol. 49 (2007) 39-45
48. Block G., Jensen C.D., Morrow J.D., Holland N., Norkus E.P., Milne G.L., Hudes M., Dalvi T.B., Crawford P.B., Fung E.B., Schumacher L., and Harmatz P. The effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level. Free Radic. Biol. Med. 45 (2008) 377-384
49. Roberts II L.J., Oates J.A., Linton M.F., Fazio S., Meador B.P., Gross M.D., Shyr Y., and Morrow J.D. The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic. Biol. Med. 43 (2007) 1388-1393
50. Blumberg J.B., and Frei B. Why clinical trials of vitamin E and cardiovascular diseases may be fatally flawed. Commentary on "The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic. Biol. Med. 43 (2007) 1374-1376